Pharma-Bio Serv Inc. (OTCMKTS:PBSV – Get Free Report) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $0.52 and traded as high as $0.53. Pharma-Bio Serv shares last traded at $0.4231, with a volume of 6,000 shares.
Pharma-Bio Serv Price Performance
The business’s 50-day simple moving average is $0.52 and its 200-day simple moving average is $0.53.
Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) last posted its quarterly earnings results on Monday, June 15th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.02). Pharma-Bio Serv had a return on equity of 0.56% and a net margin of 0.68%.The company had revenue of $2.70 billion during the quarter, compared to analyst estimates of $2.70 million. As a group, equities analysts expect that Pharma-Bio Serv Inc. will post 0.07 earnings per share for the current year.
Pharma-Bio Serv Company Profile
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Further Reading
- Five stocks we like better than Pharma-Bio Serv
- The Path to $230 Billion: Broadcom Outlines the Next Phase of Its AI Growth Story
- NVIDIA’s Hugging Face Deal Raises a Bigger Question About Its AI Moat Now
- Dropping the Dough: Yum! Brands Strategically Trims the Fat
- These 3 Stock Charts Just Flashed the Dreaded Death Cross Pattern
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.
